Market News & Trends
Frost & Sullivan Unveils Future Opportunities for Tissue Diagnostics Market
The global market for tissue diagnostic products accounted for $2.4 billion in 2012 and is estimated to reach $3.5 billion by 2017. Together, Europe and…
Novozymes Biopharma Announces Major Collaboration With Almac
Novozymes Biopharma recently announced its new collaboration with Almac to provide a combined service for drug development applications in the field of drug targeting and…
InnoCore Enters Exclusive License Agreement With Allergan
InnoCore Pharmaceuticals recently announced it has signed an exclusive license and collaboration agreement with Allergan, Inc. Under the agreement, the companies will expand their existing…
Polyplus-Transfection & Merck Sign License & Supply Agreement
Polyplus-transfection SA and Merck recently announced a global prior use license agreement and extended supply agreement for Polyplus-transfection’s polyethylenimine (PEI)-based transfection reagents. Financial details were…
Rexam & Lilly Celebrate Site Extension Summary
Rexam recently announced the extension of its Rexam Healthcare site at La Verpillière, France. The new production unit is now operational and on October 2,…
Sideris Secures $32 Million, Could be Acquired by Novartis for $300 Million
Sideris Pharmaceuticals, Inc., recently announced it has successfully completed a $32-million Series A equity financing. This investment was led by MPM Capital, including MPM’s SunStates…
PolyTherics & TUBE Pharma Form Development Collaboration
PolyTherics Limited and TUBE Pharma GmbH recently announced they are collaborating to produce reagents to link novel cytotoxic drugs developed by TUBE to antibodies using…
Frost & Sullivan: Technological Innovation Widens Global Application of Mass Spectrometry
The global mass spectrometry (MS) market is growing much faster than the high-end analytical instrumentation market. This is a sign that demand is high in…
DPT Laboratories & Confab to Integrate
DPT Laboratories and Confab recently announced the integration of the organizations under the leadership of Paul Johnson, Group President and COO. Both DPT and Confab…
Regeneron & Sanofi Report Positive Top-Line Results
Sanofi and Regeneron Pharmaceuticals, Inc. recently announced that the Phase III ODYSSEY MONO trial with alirocumab, an investigational monoclonal antibody targeting PCSK9 (proprotein convertase subtilisin/kexin…
Stallergenes & DBV Technologies Announce $198-Million Deal
Stallergenes S.A., and DBV Technologies recently announced they have entered into a research and development agreement for the treatment of birch allergy. This collaboration is…
EMD Millipore to be Global Distributor for SmartRNAplex MicroRNA Profiling Assay
EMD Millipore, the Life Science division of Merck KGaA of Darmstadt, Germany, recently announced they have entered into an agreement with Firefly BioWorks to be…
Vetter to Construct New Filling Lines to Expand Capacity
Vetter recently announced it is investing more than $100 million across its production sites in Germany and the United States. Expanding and upgrading its facilities…
Catalent Continues Major Growth Drive With Latest Acquisition Into Emerging Markets
Catalent Pharma Solutions recently announced the acquisition of Relthy Laboratórios in Brazil. Catalent continues to build upon its global leadership position by expanding its operations…
BioDelivery Sciences International Announces NDA Acceptance
BioDelivery Sciences International, Inc. recently announced that its NDA for BUNAVAIL (buprenorphine naloxone buccal film) for the maintenance treatment of opioid dependence has been accepted…
Rexahn In-Licenses Novel Oligonucleotide Targeted Drug Delivery Platform
Rexahn Pharmaceuticals, Inc. recently announced it has signed an exclusive license agreement with the Ohio State Innovation Foundation, an affiliate of The Ohio State University,…
Aegis Therapeutics Awarded its First Patent for Non-Invasive Delivery of Protein Drug to CNS
Aegis Therapeutics LLC recently announced it has been awarded its first patent for non-invasive delivery of a protein drug to the central nervous system (CNS).…
North American Drug Delivery Technologies Market Worth $102.2 Billion by 2017
Patent expiry of major blockbuster drugs is a prime concern for pharmaceutical companies, as developing a new chemical entity (NCE) is more expensive and time…
Greek Market to Show Modest Growth; Indian Market to Reach $56 billion
The growing prevalence of chronic diseases and an increasing elderly population will boost the Greek pharmaceutical market, which will increase from approximately $7.8 billion in…
Bright Future Ahead for Biopharmaceutical Contract Manufacturing
Considerable growth opportunities lie ahead for biopharmaceutical contract manufacturing organizations (CMOs). With blockbuster biologics worth over $100 billion due to lose patent protection by 2019,…
